(Q43524361)

English

Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study (English)

1 reference

Europe PubMed Central

24 November 2017

0 references

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giuseppe Daniele

2

1 reference

Europe PubMed Central

24 November 2017

Amalia Gastaldelli

11

1 reference

Europe PubMed Central

24 November 2017

Massimo Federici

object named as

Massimo Federici

10

0 references

Francesco Andreozzi

object named as

Francesco Andreozzi

9

0 references

object named as

Franco Folli

13

0 references

Ralph A. DeFronzo

12

object named as

Ralph A Defronzo

1 reference

Europe PubMed Central

24 November 2017

author name string

Devjit Tripathy

1

1 reference

Europe PubMed Central

24 November 2017

Teresa V Fiorentino

3

1 reference

Europe PubMed Central

24 November 2017

Zandra Perez-Cadena

4

1 reference

Europe PubMed Central

24 November 2017

Alberto Chavez-Velasquez

5

1 reference

Europe PubMed Central

24 November 2017

Subhash Kamath

6

1 reference

Europe PubMed Central

24 November 2017

Paolo Fanti

7

1 reference

Europe PubMed Central

24 November 2017

Christopher Jenkinson

8

1 reference

Europe PubMed Central

24 November 2017

publication date

30 June 2013

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

56

1 reference

Europe PubMed Central

24 November 2017

10

1 reference

Europe PubMed Central

24 November 2017

2153-2163

1 reference

Europe PubMed Central

24 November 2017

https://scigraph.springernature.com/pub.10.1007/s00125-013-2976-z

0 references

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Fractalkine: a cellular link between adipose tissue inflammation and vascular pathologies

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Pioglitazone for diabetes prevention in impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Effect of various diuretic treatments on rosiglitazone-induced fluid retention.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

ISEC: a program to calculate insulin secretion.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

A continuous fluorimetric assay for tumor necrosis factor-alpha converting enzyme

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Thiazolidinediones improve beta-cell function in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Comparative study of low-dose pioglitazone or metformin treatment in Japanese diabetic patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Muscles, exercise and obesity: skeletal muscle as a secretory organ

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

CD14 modulates inflammation-driven insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

A new class of membrane-bound chemokine with a CX3C motif

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Rosiglitazone activation of PPARgamma suppresses fractalkine signaling

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Efficacy and safety of low-dose pioglitazone after primary coronary angioplasty with the use of bare metal stent in patients with acute myocardial infarction and with type 2 diabetes mellitus or impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2976-Z

21 January 2018

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23811853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population

1 reference

https://pubmed.ncbi.nlm.nih.gov/23811853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/23811853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23811853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23811853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23811853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-013-2976-Z

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43524361&oldid=2098093713"